IL6 and cancer: Interestingly, IL-6-mediated activation and the phosphorylation of STAT3 enhances glycolytic effect in C26 colon cancer, which in turn amplifies EV secretion that can further contribute to the induction of skeletal muscle and adipose tissue atrophy, leading to the development of cancer cachexia [111].